KLOW Blend

Know your compound

What is KLOW Blend?

KLOW is a four-component peptide blend comprising GHK-Cu, KPV, BPC-157, and TB-500, formulated for in vitro investigation of overlapping repair and inflammatory signalling pathways. Each component acts through a distinct molecular mechanism: GHK-Cu modulates gene transcription, KPV interferes with pro-inflammatory cytokine cascades, and BPC-157 and TB-500 target complementary aspects of tissue remodelling.

GHK-Cu was reported to shift expression of 4,192 human genes toward patterns associated with younger tissue in a transcriptomic analysis, a breadth of transcriptional influence that positions it as a broad-spectrum epigenetic probe. Combined with KPV's documented suppression of TNF-α and IL-6 in cell-based assays, and the established mechanistic overlap between BPC-157 and TB-500 in angiogenic and cytoskeletal repair models, the blend is studied as a tool for dissecting multi-pathway responses to tissue challenge.

• GHK-Cu modulated 4,192 human genes toward younger expression patterns in transcriptomic analysis (Pickart & Margolina)
• KPV downregulated TNF-α and IL-6 in published inflammatory cell-based assays
• BPC-157 and TB-500 act through complementary angiogenic and cytoskeletal repair pathways across hundreds of preclinical studies